Kathryn Nevel is a Neurology physician affiliated with Indiana University Health. OpenAlex indexes 59 publications with 915 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
355 W 16th St Ste 5400
Indianapolis, IN 462022393
Telephone
317-963-5450Provider last certified this registry record 5 Mar 2025.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Telix PharmaceuticalsProgram year20253 payments
- Alexion Pharmaceuticals, Inc.Program year20253 payments
- SERVIER PHARMACEUTICALS LLCProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
80.4%Other antiepileptics46.1%Lacosamide55%Levetiracetam46%Part D≥24 patientsGabapentinoids18.4%Gabapentin64%Pregabalin36%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
8.8%Serotonin-3 Receptor Antagonist5.8%Ondansetron Hcl100%Part D≥15 patientsCorticosteroid3%Prednisone100%Part D<11 patientsSensory organs
4.6%Corticosteroid4.6%Dexamethasone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Sravanti Rangaraju, MBBS
Indiana University Health
Martin Earle, MD
Indiana University Health
Martin Farlow, MD
Indiana University Health
Lawrence Einhorn, MD
Indiana University Health
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”